Elevated systemic inflammation predicts vascular recurrence after atrial fibrillation-related stroke, supporting anti-inflammatory therapy trials targeting high-inflammatory patients.
Elevated inflammatory markers may predict vascular recurrence after AF-related stroke, providing a rationale for investigating anti-inflammatory therapies in this population.
Absolute Event Rate: 0% vs 0%
These data highlight the importance of inflammatory mechanisms in vascular recurrence irrespective of AF, provide rationale for the inclusion of patients with AF in trials of anti-inflammatory therapy, and support a selection approach in future trials based on elevated inflammatory marker levels, rather than stroke etiology alone.
McCabe et al. (Mon,) reported a other. Elevated systemic inflammation predicts vascular recurrence after atrial fibrillation-related stroke, supporting anti-inflammatory therapy trials targeting high-inflammatory patients.